482 related articles for article (PubMed ID: 22925191)
1. Fatal cases of gestational trophoblastic neoplasia over four decades in the Netherlands: a retrospective cohort study.
Lybol C; Centen DW; Thomas CM; ten Kate-Booij MJ; Verheijen RH; Sweep FC; Ottevanger PB; Massuger LF
BJOG; 2012 Nov; 119(12):1465-72. PubMed ID: 22925191
[TBL] [Abstract][Full Text] [Related]
2. Gestational trophoblastic disease: a 21-year review of the clinical experience at an Argentinean public hospital.
Bianconi MI; Otero S; Moscheni O; Alvarez L; Storino C; Jankilevich G
J Reprod Med; 2012; 57(7-8):341-9. PubMed ID: 22838252
[TBL] [Abstract][Full Text] [Related]
3. Clinical epidemiology and management of gestational trophoblastic neoplasia in Hungary in the past 34 years.
Fülöp V; Szigetvári I; Szepesi J; Végh G; Singh M; Berkowitz RS
J Reprod Med; 2012; 57(7-8):310-8. PubMed ID: 22838247
[TBL] [Abstract][Full Text] [Related]
4. Hepatic metastasis in gestational trophoblastic neoplasia: patient characteristics, prognostic factors, and outcomes.
Barber EL; Schink JC; Lurain JR
J Reprod Med; 2014; 59(5-6):199-203. PubMed ID: 24937957
[TBL] [Abstract][Full Text] [Related]
5. Treatment and prognosis of post term choriocarcinoma in The Netherlands.
Lok CA; Ansink AC; Grootfaam D; van der Velden J; Verheijen RH; ten Kate-Booij MJ
Gynecol Oncol; 2006 Nov; 103(2):698-702. PubMed ID: 16790263
[TBL] [Abstract][Full Text] [Related]
6. Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience.
Al-Husaini H; Soudy H; Darwish A; Ahmed M; Eltigani A; Edesa W; Elhassan T; Omar A; Elghamry W; Al-Hashem H; Al-Hayli S; Madkhali I; Ahmad S; Al-Badawi IA
Clin Transl Oncol; 2015 May; 17(5):409-15. PubMed ID: 25398721
[TBL] [Abstract][Full Text] [Related]
7. High-risk gestational trophoblastic neoplasia at Gujarat Cancer and Research Institute: thirteen years of experience.
Chauhan A; Dave K; Desai A; Mankad M; Patel S; Dave P
J Reprod Med; 2010; 55(7-8):333-40. PubMed ID: 20795348
[TBL] [Abstract][Full Text] [Related]
8. Treatment Outcomes of Gestational Trophoblastic Neoplasia in King Chulalongkorn Memorial Hospital over Two Decades.
Lertkhachonsuk R; Wairachpanich V
J Reprod Med; 2016; 61(5-6):238-42. PubMed ID: 27424366
[TBL] [Abstract][Full Text] [Related]
9. Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in France.
Descargues P; Hajri T; Massardier J; Lotz JP; Devouassoux-Shisheboran M; Allias Montmayeur F; You B; Golfier F; Bolze PA
Am J Obstet Gynecol; 2021 Oct; 225(4):401.e1-401.e9. PubMed ID: 34019886
[TBL] [Abstract][Full Text] [Related]
10. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.
Dantas PR; Maestá I; Cortés-Charry R; Growdon WB; Braga A; Rudge MV; Berkowitz RS
J Reprod Med; 2012; 57(7-8):305-9. PubMed ID: 22838246
[TBL] [Abstract][Full Text] [Related]
11. Deaths from gestational trophoblastic neoplasia: any lessons to be learned?
Kingdon SJ; Coleman RE; Ellis L; Hancock BW
J Reprod Med; 2012; 57(7-8):293-6. PubMed ID: 22838243
[TBL] [Abstract][Full Text] [Related]
12. High-risk metastatic gestational trophoblastic neoplasia. Primary management with EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy.
Cagayan MS
J Reprod Med; 2012; 57(5-6):231-6. PubMed ID: 22696818
[TBL] [Abstract][Full Text] [Related]
13. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
[TBL] [Abstract][Full Text] [Related]
14. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole.
Lurain JR
Am J Obstet Gynecol; 2010 Dec; 203(6):531-9. PubMed ID: 20728069
[TBL] [Abstract][Full Text] [Related]
15. Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia.
Lybol C; Sweep FC; Harvey R; Mitchell H; Short D; Thomas CM; Ottevanger PB; Savage PM; Massuger LF; Seckl MJ
Gynecol Oncol; 2012 Jun; 125(3):576-9. PubMed ID: 22410329
[TBL] [Abstract][Full Text] [Related]
16. Brain metastases in gestational trophoblast neoplasia: an update on incidence, management and outcome.
Savage P; Kelpanides I; Tuthill M; Short D; Seckl MJ
Gynecol Oncol; 2015 Apr; 137(1):73-6. PubMed ID: 25598530
[TBL] [Abstract][Full Text] [Related]
17. Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy.
Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
J Reprod Med; 2010; 55(7-8):279-84. PubMed ID: 20795339
[TBL] [Abstract][Full Text] [Related]
18. Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: A 12-year review at the Philippine General Hospital.
Cagayan MS; Lu-Lasala LR
J Reprod Med; 2006 Oct; 51(10):785-92. PubMed ID: 17086807
[TBL] [Abstract][Full Text] [Related]
19. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis.
Alifrangis C; Agarwal R; Short D; Fisher RA; Sebire NJ; Harvey R; Savage PM; Seckl MJ
J Clin Oncol; 2013 Jan; 31(2):280-6. PubMed ID: 23233709
[TBL] [Abstract][Full Text] [Related]
20. Role of surgery in the management of high-risk gestational trophoblastic neoplasia.
Lurain JR; Singh DK; Schink JC
J Reprod Med; 2006 Oct; 51(10):773-6. PubMed ID: 17086805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]